三阴性乳腺癌免疫治疗和靶向治疗的最新进展
Recent Advances in Immunotherapy and Targeted Therapy of Triple Negative Breast Cancer.
34.6分
★☆☆☆☆
站内排序·非疗效
MODALITY HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Recent Advances in Immunotherapy and Targeted Therapy of Triple Negative Breast Cancer.
Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer.
MEMBER ACCOUNT
登录成功会直接打开下一页。